Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

TAXES ON INCOME (Narrative) (Details)

v3.23.1
TAXES ON INCOME (Narrative) (Details) - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Major Components Of Income Tax Expense [Line Items]    
Applicable tax rate 26.50% 26.50%
Deferred tax assets $ 763 $ 16
Israel [Member]    
Major Components Of Income Tax Expense [Line Items]    
Applicable tax rate 23.00% 23.00%
Carryforward operating tax losses $ 6,876  
Tax losses for future without any time limitation $ 3,178  
Canada [Member]    
Major Components Of Income Tax Expense [Line Items]    
Applicable tax rate 26.50% 26.50%
Adjupharm GmbH ("Adjupharm") [Member]    
Major Components Of Income Tax Expense [Line Items]    
Applicable tax rate 29.10%  
Adjupharm GmbH ("Adjupharm") [Member] | German [Member]    
Major Components Of Income Tax Expense [Line Items]    
Carryforward operating tax losses $ 13,166  
Description of carryforward losses for tax purposes Accumulated tax losses can be carried forward without time restrictions and can be deducted from future profits and capital gains unless they exceed €1,000 thousand (approximately $1,445). Any excess of such amount will be limited to 60% of the profits or capital gains